文献速递胸部肿瘤放疗放疗物理与技术

每日锥形束CT图像引导可能降低不可切除非小细胞肺癌的放射性肺炎

Daily Image Guidance With Cone Beam Computed Tomography May Reduce Radiation Pneumonitis in Unresectable Non-Small Cell Lung Cancer.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2018-03-30

本研究比较不可手术非小细胞肺癌根治性放化疗患者每日CBCT(76例)与每日二维正交kV成像(48例)的结局,主要终点为≥2级放射性肺炎(RP2)。CBCT组1年RP2累积发生率低于kV组(24% vs 44%,P=.020),多因素分析调整后风险比0.43(95%CI 0.22-0.82,P=.011)。两组局部区域进展、远处转移、任何进展及总生存均无差异。

要点

  • CBCT组1年RP2累积发生率为24%,二维正交kV组为44%(P=.020)。
  • 多因素分析中CBCT与RP2风险降低相关(调整HR 0.43,95%CI 0.22-0.82,P=.011)。
  • 两组局部区域进展、远处转移、任何进展及总生存均无差异。

核心结论

  • 每日CBCT图像引导放疗与二维正交kV成像相比,与RP2风险降低相关。
  • 作者认为临床医生在根治性放疗时可考虑定位方法的影响。

研究设计与样本

  • 比较不可手术非小细胞肺癌接受根治性放化疗的患者:每日CBCT组76例,每日二维正交kV组48例。
  • CBCT组在初始四维CT模拟后进行每日CBCT;主要终点为至≥2级放射性肺炎时间,用累积发生率法估计、Gray检验比较、Fine-Gray模型建模。

主要发现

  • 中位随访时间CBCT组为40.6个月(范围5.9-58.1个月),二维正交kV组为75.8个月(范围9.9-107.8个月)。
  • 四维CT模拟使用率CBCT组为100%(76例),二维正交kV组为56%(27例)(P<.0001)。
  • 1年RP2累积发生率CBCT组低于二维正交kV组(24% vs 44%,P=.020)。
  • 多因素分析中,初始四维CT模拟后每日CBCT与RP2风险降低相关(调整HR 0.43,95%CI 0.22-0.82,P=.011);仅在接受四维CT模拟的患者中该关联仍存在(调整HR 0.48,95%CI 0.23-0.98,P=.045)。
  • 两组局部区域进展、远处转移、任何进展及总生存均无差异。

关键数值与推荐

  • 1年RP2累积发生率:CBCT组24% vs 二维正交kV组44%(P=.020)。
  • RP2调整HR 0.43(95%CI 0.22-0.82,P=.011),CBCT组较二维正交kV组风险降低。
  • 仅四维CT模拟患者中RP2调整HR 0.48(95%CI 0.23-0.98,P=.045)。

临床怎么用

  • 作者认为临床医生在根治性放疗时可考虑定位方法的影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the impact of daily image-guided radiation therapy technique on clinical outcomes in patients with inoperable non-small cell lung cancer treated with definitive chemoradiation therapy. METHODS AND MATERIALS: We compared patients with inoperable non-small cell lung cancer receiving daily cone beam computed tomography (CBCT) after an initial 4-dimensional computed tomography (4DCT) simulation (n = 76) with those receiving daily 2-dimensional orthogonal kilovoltage (kV) imaging (n = 48). The primary endpoint was time to grade ≥2 radiation pneumonitis (RP2), estimated with the cumulative incidence method, compared with Gray's test, and modeled with the Fine-Gray method. RESULTS: Median follow-up was 40.6 months (range, 5.9-58.1 months) for the CBCT group and 75.8 months (range, 9.9-107.8 months) for the orthogonal kV group. Four-dimensional computed tomography simulation was used in 100% (n = 76) of the CBCT group and 56% (n = 27) of the orthogonal kV group (P < .0001). The 1-year cumulative incidence of RP2 was lower in the CBCT group than in the orthogonal kV group (24% vs 44%, P = .020). On multivariate analysis, daily imaging with CBCT after an initial 4DCT simulation was associated with a decreased risk of RP2 (adjusted hazard ratio 0.43, 95% confidence interval 0.22-0.82, P = .011), a finding that persisted among only patients who received 4DCT simulation (adjusted hazard ratio 0.48, 95% confidence interval 0.23-0.98, P = .045). There was no difference in locoregional progression, distant metastasis, any progression, or overall survival between groups. CONCLUSIONS: Daily image guided radiation therapy with CBCT compared with 2-dimensional orthogonal kV imaging was associated with a decreased risk of RP2. Clinicians could consider the implications of localization methods during curative intent radiation therapy.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Yegya-Raman N, Kim S, Deek MP, et al. Daily Image Guidance With Cone Beam Computed Tomography May Reduce Radiation Pneumonitis in Unresectable Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2018. PMID: 29730063. doi:10.1016/j.ijrobp.2018.03.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。